Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-09

Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation [NA]

View source ↗

Summary

Clinical trial update on the PCV chemotherapy regimen for patients with recurrent high-grade glioma harboring IDH1/2 mutations, assessing safety and effectivene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lomustine (Lomustine)
  • Procarbazine (procarbazine)
  • Vincristine (vincristine)

Snippet

Sponsor: Hebei Yanda Hospital | Conditions: Recurrent High-grade Glioma | NA | Status: UNKNOWN